Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts

Torsten Lowin(Düsseldorf University Hospital), Georg Pongratz(University Hospital Regensburg)

Cell Death and Disease

September 1, 2020

10.1038/s41419-020-02892-1

Cited by 125

Related Papers

Anti-Inflammatory Effects of Cannabigerol in Rheumatoid Arthritis Synovial Fibroblasts and Peripheral Blood Mononuclear Cell Cultures Are Partly Mediated by TRPA1

|International Journal of Molecular Sciences|2023|21

Impact of Δ9-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells

|Biomedicines|2022|10

Components of the sympathetic nervous system as targets to modulate inflammation – rheumatoid arthritis synovial fibroblasts as neuron-like cells?

|Journal of Inflammation|2023|7

Adrenergic receptors in osteoarthritic and rheumatoid synovial fibroblasts: Identification of β3 as novel player to modulate IL-6 and p38 activation

|Research Square|2021|1